Nephrotic syndrome pediatric 1 st episode treatment
Reading File
Finding Sources
Searching PubMed
"nephrotic syndrome" AND "children" AND "corticosteroids"
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading Article
PMID: 39171624
I now have excellent, comprehensive data. Let me compile a thorough, well-structured answer.
Pediatric Nephrotic Syndrome - First Episode Treatment
Overview
The vast majority of children with a first episode of nephrotic syndrome have steroid-sensitive nephrotic syndrome (SSNS), most commonly due to minimal change disease (MCD). Corticosteroids are the cornerstone of first-line treatment. A kidney biopsy is not required before starting steroids if the presentation is typical.
When to Biopsy Before Treatment
Biopsy is indicated before starting steroids if any atypical features are present:
- Age < 1 year at presentation
- Macroscopic hematuria
- Persistent hypertension
- Hypocomplementemia (low C3/C4)
- Extrarenal symptoms (rash, arthritis - suggesting secondary cause like lupus)
- Failure to respond to steroids (steroid-resistant NS)
First-Episode Steroid Protocol (KDIGO 2021 Guidelines)
Induction Phase
| Parameter | Dose |
|---|---|
| Drug | Oral prednisone or prednisolone |
| Dose | 60 mg/m²/day or 2 mg/kg/day |
| Maximum | 60 mg/day (children); 80 mg/day (adolescents) |
| Duration | 4 to 6 weeks (single morning daily dose) |
| Administration | Single morning dose preferred (equal efficacy vs TID, less adrenal suppression, better adherence) |
Most children enter remission during induction. Complete remission = urine protein dipstick negative or trace on 3+ consecutive days (or uPCR < 0.2 mg/mg).
Maintenance/Tapering Phase
| Parameter | Dose |
|---|---|
| Drug | Same oral prednisone/prednisolone |
| Dose | 40 mg/m² or 1.5 mg/kg on alternate days |
| Duration | 4 to 6 weeks, then taper |
Key evidence on duration: The 2024 Cochrane meta-analysis (Hahn et al., PMID 39171624) reviewed 54 RCTs with 4,670 children and found high-certainty evidence that there is no benefit to extending prednisone therapy beyond 2-3 months for the first episode - longer courses (5-7 months) do not reduce relapse rates compared to 2-3 month courses. The PREDNOS RCT confirmed this finding.
Definitions to Know (KDIGO/ISKDC)
| Term | Definition |
|---|---|
| SSNS | Complete remission within 4 weeks of full-dose steroids |
| SRNS | No complete remission after 4 weeks of standard steroids |
| Relapse | Dipstick ≥ 3+ for 3 consecutive days (or ≥1+ for 7 days) after remission |
| IRNS | ≤1 relapse/6 months or < 4 relapses/year |
| FRNS | ≥2 relapses/6 months or ≥4 relapses/year |
| SDNS | Relapse during steroid taper or within 15 days of stopping steroids |
Supportive Management
Edema
- Mild edema: dietary sodium restriction is usually sufficient
- Moderate/severe edema: loop diuretics (furosemide) - use cautiously to avoid intravascular volume depletion
Infection Risk
- Children with nephrotic syndrome are at risk of pneumococcal infection (loss of immunoglobulins in urine)
- Pneumococcal vaccine should be given (ideally when in remission, not during high-dose steroids)
- Avoid live vaccines during immunosuppression
- Treat any active infection promptly; steroids should be continued (not stopped abruptly during intercurrent illness - may need to increase to daily dosing during infections to prevent relapse)
Thrombosis Prophylaxis
- Risk of VTE is elevated (loss of antithrombotic proteins in urine)
- Low-molecular-weight heparin or warfarin if serum albumin < 2 g/dL
- Switch to aspirin once albumin rises above 2 g/dL
Hyperlipidemia
- Usually resolves with remission; specific treatment rarely needed in children for first episode (more relevant for prolonged/refractory cases)
- Statins if required
Expected Response and Prognosis
- ~90-95% of children with typical nephrotic syndrome achieve remission with steroids (reflecting underlying MCD in most)
- ~50% of SSNS children will have multiple relapses
- Frequent relapses or steroid dependence require second-line agents (levamisole, cyclophosphamide, mycophenolate mofetil, calcineurin inhibitors - rituximab for refractory cases)
Summary Protocol (Quick Reference)
1st Episode - Typical Presentation
↓
Prednisone 2 mg/kg/day (max 60 mg/day)
Daily × 4-6 weeks
↓
Switch to alternate-day dosing
40 mg/m² or 1.5 mg/kg on alternate days × 4-6 weeks
↓
Taper and stop (total course ~2-3 months)
↓
Monitor urine protein (dipstick) regularly
Sources:
- Comprehensive Clinical Nephrology, 7th Edition, Chapter 18 (Initial Treatment, p. 265)
- Campbell Walsh Wein Urology, Chapter 21 (Nephrotic Syndrome, p. 459)
- KDIGO 2021 Clinical Practice Guidelines for Nephrotic Syndrome in Children
- Hahn et al., Cochrane Database Syst Rev 2024 - Corticosteroid therapy for nephrotic syndrome in children (54 RCTs, 4,670 children, high-certainty evidence)
This is a shared conversation. Sign in to Orris to start your own chat.